We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$686M
AUM Growth
+$18.6M
Cap. Flow
+$4.97M
Cap. Flow %
0.72%
Top 10 Hldgs %
30.67%
Holding
184
New
8
Increased
51
Reduced
55
Closed
15

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$8.5M
2
SLB icon
SLB Ltd
SLB
+$6.96M
3
DG icon
Dollar General
DG
+$5.73M
4
CAT icon
Caterpillar
CAT
+$3.26M
5
AXP icon
American Express
AXP
+$2.39M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$8.19M
2
IQV icon
IQVIA
IQV
+$7.69M
3
HSY icon
Hershey
HSY
+$7.55M
4
CSCO icon
Cisco
CSCO
+$3.17M
5
DIS icon
Walt Disney
DIS
+$1.55M

Sector Composition

Rank Sector Weight
1 Financials 17.8%
2 Technology 17.13%
3 Healthcare 16.58%
4 Consumer Discretionary 11.86%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPRX
151
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$158K 0.02%
10,000
TYME
152
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$130K 0.02%
41,000
+10,000
+32% +$28.5K
NVLN
153
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$96K 0.01%
26,000
MLNT
154
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$80K 0.01%
2,530
-80
-3% -$2.88K
RIGL icon
155
Rigel Pharmaceuticals
RIGL
$686M
$59K 0.01%
2,100
+100
+5% +$3.56K
PDLI
156
DELISTED
PDL BioPharma, Inc.
PDLI
$47K 0.01%
20,000
ARLZ
157
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$34K 0.01%
96,429
TOVX icon
158
Theriva Biologics
TOVX
$10.3M
$31K ﹤0.01%
15
+1
+7% +$2.3K
BFH icon
159
Bread Financial
BFH
$4.51B
-2,775
Closed -$472K
ECL icon
160
Ecolab
ECL
$78.4B
-1,667
Closed -$228K
FCNCA icon
161
First Citizens BancShares
FCNCA
$25.2B
-2,593
Closed -$1.07M
GLO
162
Clough Global Opportunities Fund
GLO
$252M
-21,486
Closed -$230K
IQV icon
163
IQVIA
IQV
$38.6B
-78,425
Closed -$7.69M
NTR icon
164
Nutrien
NTR
$31.5B
-4,424
Closed -$209K
SBUX icon
165
Starbucks
SBUX
$118B
-141,460
Closed -$8.19M
SHW icon
166
Sherwin-Williams
SHW
$85.9B
-2,262
Closed -$296K
STAY
167
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
-10,955
Closed -$217K
FCSC
168
DELISTED
Fibrocell Science Inc.
FCSC
-3,333
Closed -$10K
MON
169
DELISTED
Monsanto Co
MON
-1,920
Closed -$224K
CWBS
170
DELISTED
COMMONWEALTH BANKSHARES INC VA
CWBS
-11,761
Closed
HAWK
171
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
-11,007
Closed -$492K
GPM
172
DELISTED
Guggenheim Enhanced Equity Income Fund
GPM
-11,474
Closed -$96K

Similar funds

Franklin Street Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Franklin Street Advisors held 184 positions worth $686M, up 2.8% from $667M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Franklin Street Advisors's Q2 2018 filing shows 8 new, 51 increased, 55 reduced and 15 closed positions. Its largest new stake was NXP Semiconductors: 77,135 shares worth $8.43M. The largest sale was Starbucks, an estimated $8.19M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Franklin Street Advisors's largest Q2 2018 buy was NXP Semiconductors: 77,135 shares worth $8.43M.
  • Franklin Street Advisors added most to SLB Ltd in Q2 2018, an estimated $6.96M increase.
  • Franklin Street Advisors's biggest Q2 2018 reduction was Hershey, cutting an estimated $7.55M.
  • Franklin Street Advisors fully exited Starbucks in Q2 2018, selling an estimated $8.19M.
  • Franklin Street Advisors's ten largest holdings make up 31% of its $686M portfolio in Q2 2018.
  • Franklin Street Advisors opened 8 new positions and closed 15 in Q2 2018.
  • Franklin Street Advisors's portfolio value rose 2.8% quarter-over-quarter to $686M.

Based on Franklin Street Advisors's 13F filing for Q2 2018, filed 16 Jul 2018.